首页> 外文期刊>Infection control and hospital epidemiology >Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients.
【24h】

Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients.

机译:盐酸奥替尼定可用于严重免疫受损患者的中心静脉导管插入部位的护理。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine the efficacy and tolerability of octenidine hydrochloride, a non-alcoholic skin antiseptic, for the care of central venous catheter (CVC) insertion sites. DESIGN: Prospective, observational study. SETTING: Bone marrow transplantation unit of a university hospital. PATIENTS: All consecutive patients with a nontunneled CVC were enrolled prospectively after informed consent. METHODS: Octenidine hydrochloride (0.1%) was applied for disinfection at the CVC insertion site during dressing changes. The following cultures were performed weekly as well as at the occurrence of any systemic inflammatory response syndrome criteria: cultures of the skin surrounding the CVC entry site, cultures of the three-way hub connected to the CVC, blood cultures, and cultures of the CVC tip on removal. Enhanced microbiological methods (skin swabs of a 24-cm2 standardized area, roll plate, and sonication of catheter tips) were applied. RESULTS: One hundred thirty-five CVCs were inserted in 62 patients during the study period and remained for a mean period of 19.1 days, corresponding to 2,462 catheter-days. Bacterial density at the insertion site declined substantially over time, and most cultures became negative 2 weeks after insertion. Only 6 patients had a documented catheter-related bloodstream infection. The incidence density was 2.39 catheter infections per 1,000 catheter-days. No side effects were noted with application of the antiseptic. CONCLUSIONS: Disinfection with a skin antiseptic that contains octenidine hydrochloride is highly active and well tolerated. It leads to a decrease in skin colonization over time and may be a new option for CVC care.
机译:目的:确定盐酸奥替尼定(一种非酒精性皮肤消毒剂)在中央静脉导管(CVC)插入部位的护理中的功效和耐受性。设计:前瞻性观察研究。单位:大学医院的骨髓移植科。患者:所有连续的无隧道CVC患者均在知情同意后进行前瞻性研究。方法:在换药期间,将盐酸奥替尼定(0.1%)用于CVC插入部位进行消毒。每周以及在发生任何系统性炎症反应综合征标准时进行以下培养:CVC进入部位周围皮肤的培养,与CVC连接的三向枢纽的培养,血液培养和CVC的培养移除提示。应用了增强的微生物学方法(标准面积为24 cm2的拭子,卷板和导管尖端的超声处理)。结果:在研究期间,在62例患者中插入了135个CVC,平均停留时间为19.1天,相当于2,462个导管天。插入部位的细菌密度随时间大幅下降,大多数培养物在插入后2周变为阴性。只有6例患者有记录的与导管相关的血液感染。发生密度为每1,000个导管日2.39例导管感染。使用该抗菌剂未发现副作用。结论:使用含有盐酸奥替尼定的皮肤消毒剂具有很高的活性,并且具有良好的耐受性。随着时间的推移,它会导致皮肤定植的减少,并且可能是CVC护理的新选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号